Dolutegravir/emitricitabine/tenofovir alafenamide
- Level
- Commodity
- Parent
- 51343800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343812This classification denotes a combination drug for treatment of HIV. The first component, DOLUTEGRAVIR, has US FDA Unique Ingredient Identifier of DKO1W9H7M1. The second component, EMTRICITABINE, has US FDA Unique Ingredient Identifier of G70B4ETF4S. The third component, TENOFOVIR ALAFENAMIDE, has US FDA Unique Ingredient Identifier of EL9943AG5J.
Same parent
Under 51343800 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.